IPOs

Harpoon lands $75.6M in NASDAQ IPO
Harpoon lands $75.6M in NASDAQ IPO
BioCentury
Harpoon Therapeutics
IPOs
Flag link:
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials
Xconomy
Alector
IPOs
Alzheimer's disease
Flag link:
Cancer-Vaccine Maker BioNTech Considering an IPO in U.S.
Cancer-Vaccine Maker BioNTech Considering an IPO in U.S.
Yahoo/Bloomberg
BioNTech
IPOs
Pfizer
Sanofi
vaccines
cancer vaccines
Flag link:
Another Immuno-Oncology Company, Another $90+ Million IPO
Another Immuno-Oncology Company, Another $90+ Million IPO
CP Wire
Harpoon Therapeutics
IPOs
immuno-oncology
Flag link:
Another Immuno-Oncology Company, Another $90+ Million IPO
Harpoon Therapeutics
IPOs
immuno-oncology
Flag link:
Ophthalmic Medtech Company Avedro Launches $92 Million IPO
Ophthalmic Medtech Company Avedro Launches $92 Million IPO
CP Wire
Avedro
IPOs
eye health
corneal ectatic disorders
Flag link:
Immuno-Oncology Company Plans $92 Million IPO
Immuno-Oncology Company Plans $92 Million IPO
CP Wire
TCR2 Therapeutics
immuno-oncology
IPOs
Flag link:
Immuno-Oncology Company Plans $92 Million IPO
TCR2 Therapeutics
immuno-oncology
IPOs
Flag link:
With US government shutdown over, Gossamer reverts to traditional IPO plan
With US government shutdown over, Gossamer reverts to traditional IPO plan
Endpoints
Gossamer Bio
IPOs
government shutdown
Flag link:
Immuno-Neurology Focused Alector Files $180 Million IPO
Immuno-Neurology Focused Alector Files $180 Million IPO
CP Wire
Alector
IPOs
immuno-neurology
Flag link:
Biotechs Scramble to Get IPOs Moving Now That Government Is Open
Biotechs Scramble to Get IPOs Moving Now That Government Is Open
BioSpace
IPOs
SEC
Flag link:
Give and Take: A Look at Life Sciences IPO Withdrawals
Give and Take: A Look at Life Sciences IPO Withdrawals
BioSpace
IPOs
IPO withdrawals
Flag link:
Gosssamer Bio to Use 20 Day Rule for $230 Million IPO
Gossamer Bio
IPOs
Flag link:
Gossamer sets fixed share price for $230M IPO to sidestep shutdown
Gossamer sets fixed share price for $230M IPO to sidestep shutdown
BioCentury
Gossamer Bio
IPOs
government shutdown
Flag link:
Microbiome Report for Week Ending 1/19/19
Microbiome Report for Week Ending 1/19/19
CP Wire
microbiome
Seres Therapeutics
Synlogic
Kaleido Biosciences
IPOs
Flag link:
Amid Government Shutdown, Companies Try New Approaches to IPOs
Amid Government Shutdown, Companies Try New Approaches to IPOs
BioSpace
IPOs
government shutdown
Flag link:
As shutdown stalls IPOs, companies mull creative paths to market
As shutdown stalls IPOs, companies mull creative paths to market
Biopharma Dive
SEC
NASDAQ
IPOs
Flag link:
Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt
Alzheon hits another dead end funding its Alzheimer's program, pulls second IPO attempt
Endpoints
Alzheon
IPOs
clinical trials
ALZ-801
Alzheimer's disease
Flag link:
Brainsway registers for $30m IPO
Brainsway registers for $30m IPO
Mass Device
Brainsway
IPOs
devices
Deep Transcranial Magnetic Stimulation
Flag link:
After JPM, biotechs still scrambling for IPOs as Kaleido, Cirius file amid government shutdown
After JPM, biotechs still scrambling for IPOs as Kaleido, Cirius file amid government shutdown
Fierce Biotech
IPOs
Kaleido Biosciences
Cirius Therapeutics
NASDAQ
JPMHC 2019
government shutdown
Flag link:

Pages